Why the Incannex (ASX:IHL) share price is soaring 13%

The Incannex share price is soaring today as the company mulls a US listing. We take a closer look at its release.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Incannex Healthcare Ltd (ASX: IHL) share price is soaring today as the company announced that it is mulling a US listing. Shares in the small-cap health care stock are currently trading 12.82% higher as a result. This has held Incannex shares to rise to a price of 22 cents.

Why is the Incannex share price flying?

Today the Incannex share price is trading strongly higher. This comes as the company announced that it is intending to list on the US market. The company has executed a binding consulting agreement with EAS Advisors to facilitate the listing.

Incannex noted that the predominant purpose of the arrangement was for EAS to introduce it to US banks and institutions. With the aim of dual listing the company on either the Nasdaq Composite (INDEXNASDAQ: .IXIC) or the NYSE Composite (INDEXNYSEGIS: NYA). While also retaining its listing on the ASX.

It is worth noting that the term of the agreement is 12 months. EAS will be paid both with Incannex options and a standard retainer. The advisory firm is also going to assist with financial modelling, presentation preparation, and external data room maintenance. This will be on top of generating global investor awareness.

Management Comments

CEO and Managing Director of Incannex Healthcare, Joel Latham, welcomed the news by saying:

After several months of getting to know one another, Eddie and EAS have joined our broader team to evaluate opportunities to list IHL securities in the United States on one of the main markets. We have made this decision because of deep investor interest and corporate activity in both cannabinoid-based pharmaceuticals and psychedelic therapeutic endeavours in North America. We're delighted to be working with the team at EAS, which has an excellent track record of growing international awareness for ASX companies.

About the Incannex share price

The Incannex share price has performed well as of late as it recently released positive drug results.

In the last month alone, its shares are up a whopping 37.5%, easily outpacing the All Ordinaries Index (ASX: XAO). Incannex is currently valued at $229.24 million.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A shadow bear faces a man against the backdrop of a falling share price.
Opinions

How to invest during an ASX share bear market when you're worried about prices falling more

Is this the time to be brave or cautious about investing?

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Share Gainers

These were the best-performing ASX 200 shares in March

Here are the best-performing shares from the ASX 200 index last month.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Wednesday

It looks set to be a very good day for Aussie investors today.

Read more »

A male investor sits at his desk pondering at his laptop screen with a piece of paper in his hand.
Share Market News

Paladin Energy shares: Judicial review challenges EIS approval

Paladin Energy shares are in focus after a judicial review was filed against its key project’s EIS approval.

Read more »

Ecstatic woman on her phone giving a fist pump after reading some good news.
Opinions

5 ASX shares I'd buy with $10,000 this week

I expect these shares to rebound over the next 12 months.

Read more »

man analysing share price
Share Market News

AGL Energy gives green light to $490m Kwinana gas project

AGL gives final approval to its $490 million Kwinana gas project, targeting new growth and returns in Western Australia.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile but positive Tuesday.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Market News

Why I'd buy DroneShield and these ASX 200 shares next month

These ASX shares offer a mix of growth, resilience, and long-term opportunity.

Read more »